A detailed history of Citigroup Inc transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Citigroup Inc holds 50,408 shares of CDMO stock, worth $624,051. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,408
Previous 31,723 58.9%
Holding current value
$624,051
Previous $226,000 153.54%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.7 - $12.45 $125,189 - $232,628
18,685 Added 58.9%
50,408 $573,000
Q2 2024

Aug 12, 2024

SELL
$6.34 - $9.28 $3.69 Million - $5.4 Million
-581,939 Reduced 94.83%
31,723 $226,000
Q1 2024

May 10, 2024

BUY
$5.86 - $8.79 $2.7 Million - $4.05 Million
460,216 Added 299.92%
613,662 $4.11 Million
Q4 2023

Feb 09, 2024

BUY
$4.64 - $9.56 $217,091 - $447,283
46,787 Added 43.87%
153,446 $997,000
Q3 2023

Nov 09, 2023

SELL
$9.4 - $14.04 $525,826 - $785,383
-55,939 Reduced 34.4%
106,659 $1.01 Million
Q2 2023

Aug 10, 2023

SELL
$12.96 - $20.93 $100,336 - $162,040
-7,742 Reduced 4.55%
162,598 $2.27 Million
Q1 2023

May 11, 2023

SELL
$13.48 - $18.79 $135,137 - $188,369
-10,025 Reduced 5.56%
170,340 $3.2 Million
Q4 2022

Feb 09, 2023

SELL
$12.61 - $18.74 $81,574 - $121,229
-6,469 Reduced 3.46%
180,365 $2.48 Million
Q3 2022

Nov 10, 2022

BUY
$15.33 - $20.36 $582,769 - $773,985
38,015 Added 25.54%
186,834 $3.57 Million
Q2 2022

Aug 10, 2022

BUY
$11.63 - $21.55 $734,062 - $1.36 Million
63,118 Added 73.65%
148,819 $2.27 Million
Q1 2022

May 12, 2022

SELL
$16.63 - $27.73 $1.57 Million - $2.62 Million
-94,427 Reduced 52.42%
85,701 $1.75 Million
Q4 2021

Feb 10, 2022

BUY
$20.7 - $34.18 $2.02 Million - $3.33 Million
97,440 Added 117.84%
180,128 $5.26 Million
Q3 2021

Nov 10, 2021

BUY
$19.05 - $28.32 $1.58 Million - $2.34 Million
82,688 New
82,688 $1.78 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $770M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.